The ITC issued a Limited Exclusion Order against all Respondents and Cease and Desist Orders against Respondents Delta Electronics (Americas) Ltd., Quanta Computer USA Inc. and Quanta Computer Inc., ...

Skyharbour Resources Ltd. (TSX-V: SYH)  (OTCQX: SYHBF)  (Frankfurt: SC1P ) (“Skyharbour” or the “Company”) is pleased to announce that partner company Terra Clean Energy Corp. (“Terra”, previously ...

Outokumpu Corporation Press release/Investor news February 14, 2025 at 8.15 pm EET ...

Professor Verkooijen, who also serves as President and CEO of the Global Center on Adaptation (GCA) and Chancellor of the University of Nairobi, described how the world has entered an era of ...

On January 28, 2025, Evaxion was given until May 12, 2025, to formally evidence compliance with Nasdaq listing rule 5550 (b) (1) requiring stockholders’ equity of at least $2.5 million. The company ...

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- As a continuation of its New York Stories, DKNY shifts focus from literature to cinema for its Spring 2025 Campaign, introducing Lila Moss as the new global ...

Smart Skid – A base platform that houses the brains of the Smartstack system. The Smart Skid integrates advanced cooling equipment, power control system hardware, all cabling, and comprehensive ...

Solar Foods has begun the pre-engineering of its first industrial-scale Solein® production facility, Factory 02, marking a major step towards profitable production scale. The Factory 02 will be ...

Bitget's Protection Fund reached a peak valuation of $690 million, maintaining its upward trajectory as Bitcoin traded within a range of $87,000 to $105,000. Throughout January, the Protection Fund ...

Deutsche Telekom, one of Europe’s leading telecommunications providers, and Swift Navigation, a San Francisco-based company transforming how positioning technology is applied across industries, today ...

Salsify , the Product Experience Management (PXM) platform empowering brand manufacturers, distributors, and retailers to win on the digital shelf, today announced another year of double digit ARR ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...